264 / 464
264
POSTERS AND ELECTRONIC POSTERS
| Programme and Exhibition Guide
ELECTRONIC POSTERS
L. Barbera (Canada), C. DeAngelis, C. Earle, C. Atzema, D. Dudgeon,
D. Howell, A. Husain, M.A. O’Brien, H. Seow, J. Sussman, R. Sutradhar,
A. Chu, Y. Liu
EP-1387
> Clinical features of bone metastases and their importance for
radiotherapy
N. Bychkova (Russian Federation), E. Khmelevsky
EP-1388
> Superficial hyperthermia with radiotherapy: toxicity and outcome of 62
metastatic lesions
G. Cattari (Italy), A.G. Di Dia, M. Gatti, E. Delmastro, E. Garibaldi,
G. Belli, A. Salatino, P. Gabriele
EP-1389
> Superior target delineation of renal cell carcinoma bone metastases on
MRI vs CT
F.M. Prins (The Netherlands), J.M. Van der Velden, A.S. Gerlich,
A.N.T.J. Kotte, W.S.C. Eppinga, N. Kasperts, L.G.W. Kerkmeijer
EP-1390
> Digestive toxicity after conformal radiotherapy for palliative cervico-
thoracic spinal metastases
G. Peyraga (France), D. Caron, Y. Metayer, Y. Pointreau, F. Denis,
G. Ganem, C. Lafond, S. Roche, O. Dupuis
EP-1391
> Prognostic factors for survival in patients with bone metastases
P.M. Samper Ots (Spain), M. Hernandez Miguel, E. Amaya Escobar,
M.D. De las Peñas Cabrera
EP-1392
> Prognostic factors for survival in patients with brain metastases
P.M. Samper Ots (Spain), M. Hernandez Miguel, E. Amaya Escobar,
M.D. De las Peñas Cabrera
EP-1393
> Prognostic factor for palliative radiotherapy of bone metastases in good
performance-status patients
Y. Hamamoto (Japan), S. Taguchi, T. Manabe, H. Kanzaki, K. Nagasaki,
N. Takata, T. Mochizuki
EP-1394
> CyberKnife treatment of intraorbital metastases: a single center
experience on 24 lesions.
G. Riva (Italy), M. Augugliaro, G. Piperno, A. Ferrari, E. Rondi,
S. Vigorito, R. Orecchia, B.A. Jereczek-Fossa
EP-1395
> Versatis® and focal neuropathic pain in cancer patients (screening tool)
C. Prieto Prieto (Spain), E. López Ramirez
EP-1396